The Motley FoolInvesting What Should Investors Make of Abbott's Reduced Full-Year Guidance?verified_publisher The Motley Fool - Keith Speights and Brian Orelli, PhD The bad news: COVID-19 test volumes are falling. The good news: Abbott has other growth drivers. COVID-19 testing ain't what it used to be. That's …
Ohio Columbus Kroger Bakery redevelopment delayed as Abbott raises concerns - Columbus Business First bizjournals.com - Dan Eaton Concerns from a potential neighbor and a lack of more detailed development plans have delayed a decision on the former Kroger Bakery site. The …
TheStreetflipped into National Videos1:39Business Why Abbott Laboratories Stock Price Slumped on Tuesday TheStreet "It's actually a confirmation that the reopening is going very well right after this memorial weekend," says Jeff Marks, Senior Portfolio Analyst at Action Alerts PLUS.
Seeking AlphaInvesting Abbott Laboratories declares $0.45 dividend (NYSE:ABT)verified_publisher Seeking Alpha - Kaushik Sampat, SA News Editor • Abbott Laboratories (NYSE:ABT) declares $0.45/share quarterly dividend, in line with previous. • Forward yield 1.64% • Payable Aug. 16; for shareholders of …
desigeekflipped into InvestingInvestment Funds Here's Why You Should Buy Health Care Stocks U.S. News & World Report - By Ellen Chang Health care stocks could perform well in the coming months. Investors should consider pivoting their portfolios to health care stocks since the S&P …
The Toronto Starflipped into BusinessJim Cramer Buy-the-dip candidates: Jim Cramer would rather own DoorDash than Uberverified_publisher thestar.com - Alicia Stein Stocks declined Monday as Wall Street measured inflation risks and the implications a global tax agreement would have for the biggest technology …
Star Tribuneflipped into BusinessMedtronic Medtronic ends sales of heart-failure device Star Tribune - Joe Carlson Following reports of greater mortality and stroke risk, Medtronic pulls its HVAD device from worldwide market Medtronic PLC is discontinuing all …
Cardiovascular System The future of cardiovascular disease prevention: a risk registry approach nature.com Abbott is a global healthcare company that creates life-changing products—in diagnostics, medical devices, nutrition and branded generic …
CNBCflipped into Top NewsChromosomes Theranos is history, but big blood testing breakthroughs are coming post-Covidverified_publisher CNBC - Willem Marx One morning last May, Tayah Fernandes's mother Shannon realized her four-year-old daughter was seriously unwell, and rushed her to the nearest ER in …
Daniel Lee flipped into Covid Opinion & Analysis If We Have Vaccines, Why Do We Still Need Testing?verified_publisher Bloomberg - Max Nisen The pandemic is far from over and testing will be essential in controlling outbreaks, identifying emerging variants and allowing for safe …
Barron'sflipped into Barron'sCoronavirus (COVID-19) Abbott Labs Stock Drops as Covid Vaccinations Rise. What That Means for Earnings. Barron's - Josh Nathan-Kazis As the pandemic eases in much of the world, the need for Covid-19 tests is falling. Demand is dropping fast enough that Abbott Laboratories (ticker: …
ForbesFinance What’s Next For Abbott Stock After A 10% Drop Yesterday? Forbes - Trefis Team[Updated: 6/3/2021] Abbott Revised Guidance The stock price of Abbott (NYSE: ABT) has seen a large 10% drop over the last five trading days. The decline can be attributed to the company’s announcement...
